The Fibrosis Study

Study Objective:

• The purpose of this study is to evaluate the efficacy of a potential new treatment for systemic sclerosis (SSc) which is a rare, serious lung disease characterized by high blood pressure in the lungs & arteries, which can lead to heart failure if untreated.
• SSc is typically caused by an excess build-up of collagen. Collagen provides strength and structure to your skin, muscle, bones and connective tissue. This excess build-up of collagen is known as fibrosis.

Importance of Treatment:

• This study aims to explore more effective options, potentially improving patient outcomes and quality of life for future generations suffering with this condition.

Clinical Trial Details:

An independent ethics committee has approved this clinical trial.

Participants will be reimbursed for their time.